7-Eleven Owner's First-Quarter Net Profit Fell 35% on Weak International Business
By Kosaku Narioka
Seven & I Holdings said Thursday that its first-quarter net profit fell 35% due to weakness in its overseas-convenience-store and superstore businesses.
The Japanese operator of 7-Eleven and other retail stores said net profit for the quarter ended May fell to 42.18 billion yen ($304.5 million) from Y65.04 billion a year earlier. That missed the estimate of Y61.08 billion from a poll of analysts by FactSet.
First-quarter revenue rose 8.3% to Y2.651 trillion.
Operating profit for its overseas-convenience-store business fell 52% to Y20.98 billion and that of its superstore business declined 5.8% to Y3.32 billion, while earnings grew for its domestic-convenience-store and financial-services businesses.
Seven & I kept its revenue and net profit forecasts for the fiscal year ending February 2024. It continued to expect revenue to fall 5.6% to Y11.154 trillion and net profit to rise 1.4% to Y285.00 billion.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
July 13, 2023 03:09 ET (07:09 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track